• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：雷公藤甲素抑制糖尿病肾病中肾小球系膜细胞增殖与抑制PDK1/Akt/mTOR信号通路相关：勘误。

Erratum: Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum.

作者信息

Han Fei, Xue Mei, Chang Yunpeng, Li Xiaoyu, Yang Yang, Sun Bei, Chen Liming

机构信息

Key Laboratory of Hormones and Development (Ministry of Health), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University.

出版信息

Int J Biol Sci. 2020 Oct 3;16(15):3037-3038. doi: 10.7150/ijbs.53769. eCollection 2020.

DOI:10.7150/ijbs.53769
PMID:33061815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7545705/
Abstract

[This corrects the article DOI: 10.7150/ijbs.20485.].

摘要

[本文更正了文章的数字对象标识符：10.7150/ijbs.20485。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c0/7545705/5d7f88a8f9c4/ijbsv16p3037g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c0/7545705/5d7f88a8f9c4/ijbsv16p3037g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c0/7545705/5d7f88a8f9c4/ijbsv16p3037g001.jpg

相似文献

1
Erratum: Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum.勘误：雷公藤甲素抑制糖尿病肾病中肾小球系膜细胞增殖与抑制PDK1/Akt/mTOR信号通路相关：勘误。
Int J Biol Sci. 2020 Oct 3;16(15):3037-3038. doi: 10.7150/ijbs.53769. eCollection 2020.
2
Erratum: Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum.勘误：雷公藤甲素抑制糖尿病肾病中肾小球系膜细胞增殖与抑制PDK1/Akt/mTOR信号通路相关：勘误
Int J Biol Sci. 2024 Sep 5;20(12):4781-4782. doi: 10.7150/ijbs.101944. eCollection 2024.
3
Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.Gas6在糖尿病肾病中诱导Akt/mTOR介导的系膜细胞肥大。
Kidney Int. 2005 Aug;68(2):552-61. doi: 10.1111/j.1523-1755.2005.00433.x.
4
Role of growth arrest-specific gene 6 in diabetic nephropathy.生长停滞特异性基因6在糖尿病肾病中的作用。
Vitam Horm. 2008;78:375-92. doi: 10.1016/S0083-6729(07)00015-5.
5
Inhibition of Akt/mTOR/p70S6K Signaling Activity With Huangkui Capsule Alleviates the Early Glomerular Pathological Changes in Diabetic Nephropathy.黄葵胶囊抑制Akt/mTOR/p70S6K信号活性减轻糖尿病肾病早期肾小球病理改变
Front Pharmacol. 2018 May 23;9:443. doi: 10.3389/fphar.2018.00443. eCollection 2018.
6
Erratum: suppresses tumor growth and metastasis in nasopharyngeal carcinoma by repressing PI3K/AKT signaling pathway via interaction with Integrin β1 and Merlin: Erratum.勘误：通过与整合素β1和默林相互作用抑制PI3K/AKT信号通路从而抑制鼻咽癌的肿瘤生长和转移：勘误
Int J Biol Sci. 2023 Jan 5;19(3):829-830. doi: 10.7150/ijbs.79278. eCollection 2023.
7
Erratum: Circulating Exosomal miR-1-3p from Rats with Myocardial Infarction Plays a Protective Effect on Contrast-Induced Nephropathy via Targeting ATG13 and activating the AKT Signaling Pathway: Erratum.勘误：心肌梗死大鼠循环外泌体miR-1-3p通过靶向ATG13并激活AKT信号通路对造影剂诱导的肾病起保护作用：勘误。
Int J Biol Sci. 2023 Oct 21;19(16):5290-5291. doi: 10.7150/ijbs.86961. eCollection 2023.
8
Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway. Bergenin 通过抑制 mTOR/β-TrcP/Nrf2 通路的氧化应激，抑制肾小球系膜细胞细胞外基质的产生，改善糖尿病肾病小鼠的病情。
Free Radic Biol Med. 2019 Dec;145:118-135. doi: 10.1016/j.freeradbiomed.2019.09.003. Epub 2019 Sep 5.
9
In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway.1,25-二羟基维生素D通过DDIT4/TSC2/mTOR途径在体外和体内抑制mTOR以改善早期糖尿病肾病。
Endocrine. 2016 Nov;54(2):348-359. doi: 10.1007/s12020-016-0999-1. Epub 2016 Jul 9.
10
AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway.AS101可预防糖尿病肾病进展和系膜细胞功能障碍：对AKT下游通路的调节
PLoS One. 2014 Dec 4;9(12):e114287. doi: 10.1371/journal.pone.0114287. eCollection 2014.

引用本文的文献

1
Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.雷公藤红素通过激活 Nrf2/HO-1 通路和抑制 NLRP3 炎性小体通路来保护糖尿病肾病中的足细胞免受损伤。
Ren Fail. 2023 Dec;45(1):2165103. doi: 10.1080/0886022X.2023.2165103.
2
A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives.深入探讨肾脏疾病中调节性 T 细胞代谢：事实与展望。
Front Immunol. 2022 Feb 17;13:826732. doi: 10.3389/fimmu.2022.826732. eCollection 2022.

本文引用的文献

1
Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway.雷公藤红素抑制糖尿病肾病肾小球系膜细胞增殖与其抑制 PDK1/Akt/mTOR 通路有关。
Int J Biol Sci. 2017 Sep 21;13(10):1266-1275. doi: 10.7150/ijbs.20485. eCollection 2017.